Temporal changes in the RPR titer from before to after treatment. by Kazuhiko Ikeuchi (9234268)

“…<p>The time course of the RPR titer from before to after treatment in each group is shown (2A, increased-RPR group; 2B, stable-RPR group; 2C, decreased-RPR group). …”

H2-K^b overexpression decreases NSPC proliferation and impairs adult hippocampal neurogenesis. by Karin Lin (11037548)

Excel spreadsheet containing, in separate sheets (for each figure), the underlying numerical datas for Figure panels 1A, 1B, 1C, 2B, 3A, 3B, 3C, 4C, 4D, 4E, 4F, 4G, 5B, 8C and 8D. by Acharya Balkrishna (5640038)

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…<p>Two independent groups evaluated GCase activity in whole brain homogenate (A,C) and liver homogenate (B,D) using different methods—The CBE/4-MU method (A,B) and the MDW941 method (C,D). …”

N2142A mutation could reduce mortality rate and severity of symptoms by decreasing viral loads in limb muscle and spinal cord. by Xue Li (285380)

Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. by Daisuke Sugahara (2047696)

miR-275 and miR-305 maternal loss-of-function mutants exhibited impaired flight capability, decreased hatching rate and survival rate. by Junfei Xie (3148638)

<i>M</i>. <i>leprae</i> was detected in the liver of a multibacillary patient and can decrease ApoA-I expression in HepG2 cells. by Robertha Mariana R. Lemes (8635935)

Summary of subgroup analysis results. by Junyin Pan (20700411)

Subjects:

Original study data. by Junyin Pan (20700411)

Subjects:

Forest plot. by Junyin Pan (20700411)

Subjects:

Funnel plot. by Junyin Pan (20700411)

Subjects:

VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. by Marek J. Kobylarz (9292599)

Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric <i>in silico</i> ROCOCO trial by Daniëlle B. P. Eekers (5560430)

A-C: Post-operative lateral cervical radiograph acquired 7 years after cervical stabilization procedure at C3-4 and C4-5 (Horse #19). by Devon England (21262225)

The frequency of co-expression of ALDH and CGA progressively decreases during colon tumorigenesis in FAP patients. by Tao Zhang (43681)

“…The number of positively stained cells counted in each case included, normal crypts (n = 95), normal appearing FAP crypts (n = 90), FAP adenomatous crypts (n = 103), FAP colon carcinomas (n = 126). Fig 2F shows that in normal crypts, many cells staining for the colonic SC marker ALDH1 co-stained for chromogranin-A (CGA) and other NEC markers. …”

Pharmacological Notch inhibition decreases the penetrance of <i>mef2ca</i>-associated phenotypes without producing a skeletal phenotype in genetic wild types. by Juliana Sucharov (8067371)

Adaptation of SARS-CoV-2_Engl2 to VeroE6 and selection of decreased RDV sensitivity. by Agnieszka M. Szemiel (10196243)

Image_2_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG by Meijuan Liu (4924417)

“…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)